Doctors test 'Smart Bomb' radiation for aggressive prostate cancer
NCT ID NCT06379217
Summary
This early-stage study is testing a personalized radiation treatment for men with metastatic neuroendocrine prostate cancer, an aggressive form of the disease. Doctors first scan each patient's tumors to see which of three specific targets is most present, then deliver a matching radioactive drug designed to attack those targets. The main goals are to check if this approach is safe and to see early signs of whether it can help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC NEUROENDOCRINE PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Ctr
New York, New York, 10017, United States
-
Nebraska Cancer Specialists
Omaha, Nebraska, 68130, United States
-
Novartis Investigative Site
Nantes, 44093, France
-
Novartis Investigative Site
München, 80377, Germany
-
Novartis Investigative Site
Rostock, 18057, Germany
-
Novartis Investigative Site
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
-
Novartis Investigative Site
Madrid, 28041, Spain
-
Novartis Investigative Site
Sutton, Surrey, SM2 5PT, United Kingdom
-
Novartis Investigative Site
London, NW3 2QG, United Kingdom
-
Seattle Cancer Care Alliance
Seattle, Washington, 98109, United States
-
Stanford University
Palo Alto, California, 94304, United States
Conditions
Explore the condition pages connected to this study.